Benjamin Shaw steps down as CEO and president and will serve as a strategic advisor to the board of Covetrus . Board chair Wolin to assume role as acting CEO and president, lead independent director Laskawy to serve as board chair. PORTLAND, Maine --(BUSINESS WIRE)--Oct.

Named a preferred partner for prescription management services for their network of nearly 600 hospitals PORTLAND, Maine --(BUSINESS WIRE)--Oct. 16, 2019-- Covetrus  (NASDAQ: CVET), a global leader in animal-health technology and services, announced that it has been named a preferred prescription

  VSG selects Covetrus as a Preferred Partner for prescription management and specialty pharmacy     PORTLAND, Maine --(BUSINESS WIRE)--Oct. 1, 2019-- Covetrus  (NASDAQ: CVET), a global leader in animal-health technology and services, announced a newly expanded strategic partnership with Veterinary

  Veteran HR and operations executive with experience supporting global organizations through transformation joins Covetrus executive leadership team     PORTLAND, Maine --(BUSINESS WIRE)--Sep. 23, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today

Independent Director Benjamin Wolin Assumes Board Chair Role PORTLAND, Maine --(BUSINESS WIRE)--Sep. 4, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Benjamin Wolin as chair of its board of directors effective September

Hands-On Program Enriches Pharmacy Students with Introduction to the Practice of Veterinary Pharmacy PORTLAND, Maine --(BUSINESS WIRE)--Aug. 20, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal health-technology and services, announced that it is partnering with the University of New

Covetrus Connect ™ offers veterinary professionals an expanded menu of secure, permissions-based integrations, improving standards of care and driving practice efficiency PORTLAND, Maine --(BUSINESS WIRE)--Aug. 14, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal health technology and

Net sales of $1,009 million , relatively flat year-over-year, non-GAAP pro forma organic net sales declined 1% year-over-year In North America , net sales of $552 million , or a 6% increase year-over-year; prescription management platform net sales growth of 46% year-over-year and 22% sequentially;

PORTLAND, Maine , July 30, 2019 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2019 results the morning of Tuesday, August 13, 2019 . Following the release, the company will hold a conference

Heart + Paw to Leverage Covetrus’ Supply Chain Expertise for Their Expanding Network PORTLAND, Maine --(BUSINESS WIRE)--Jun. 25, 2019-- Covetrus  (NASDAQ: CVET), a global leader in animal-health technology and services, announced today a new strategic partnership with Heart + Paw , an integrated